Scientific Reports · 2017 · 52 citations · 29 references
Veterinary MedicineNeurologyNeuroscienceMolecular NeuroscienceNeurodegenerationPrion DiseasesFamilial Prion DiseaseFatal Familial InsomniaNeurodegenerative DiseasesNeurodegenerative DisordersNeuropathology Of Prion DiseasePrion Disease DiagnosisFamilial Prion Disease BiomarkersFatal Familial Insomnia NeuropathologyPoint Mutation EffectsPrion BiomarkersPrion Disease PathologyPrion PathogenesisPrion Protein OligomerizationPrion Seeding Activity
Abstract Fatal Familial Insomnia (FFI) is a genetic prion disease caused by a point mutation in the prion protein gene ( PRNP ) characterized by prominent thalamic atrophy, diffuse astrogliosis and moderate deposition of PrP Sc in the brain. Here, for the first time, we demonstrate that the olfactory mucosa (OM) of patients with FFI contains trace amount of PrP Sc detectable by PMCA and RT-QuIC. Quantitative PMCA analysis estimated a PrP Sc concentration of about 1 × 10 −14 g/ml. In contrast, PrP Sc was not detected in OM samples from healthy controls and patients affected by other neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia. These results indicate that the detection limit of these assays is in the order of a single PrP Sc oligomer/molecule with a specificity of 100%.
29